Although this paper did not show direct correlation with the gut mycobiome, anti-TNFα therapy, which is often given to patients with inflammatory bowel disease (IBD) has been shown to induce changes in the relative abundance of fungi in the gut [117, 118]. This evidence concerns the gene TNF and irritable bowel syndrome.